Cite
[A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls].
MLA
Haendl, T., et al. “[A Comparative Study of the Hepatic Transit Time (HTT) of Different Ultrasound Contrast Agents in Patients with Liver Metastases and Healthy Controls].” Ultraschall in Der Medizin (Stuttgart, Germany : 1980), vol. 31, no. 6, Dec. 2010, pp. 582–88. EBSCOhost, https://doi.org/10.1055/s-0028-1109953.
APA
Haendl, T., Strobel, D., Neureiter, D., Esser, K., Frieser, M., Hahn, E. G., & Bernatik, T. (2010). [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls]. Ultraschall in Der Medizin (Stuttgart, Germany : 1980), 31(6), 582–588. https://doi.org/10.1055/s-0028-1109953
Chicago
Haendl, T, D Strobel, D Neureiter, K Esser, M Frieser, E G Hahn, and T Bernatik. 2010. “[A Comparative Study of the Hepatic Transit Time (HTT) of Different Ultrasound Contrast Agents in Patients with Liver Metastases and Healthy Controls].” Ultraschall in Der Medizin (Stuttgart, Germany : 1980) 31 (6): 582–88. doi:10.1055/s-0028-1109953.